Table 7.
Top hallmark and GO biological processes pathways enriched for genes closest to DNAm probe sites in cis-mQTLs in endometrium and blood
Tissue | GeneSet | N | n | P value | Adjusted P |
---|---|---|---|---|---|
Endometrial mQTLs | Go intracellular signal transduction | 1568 | 237 | 1.92E-29 | 5.50E-26 |
Go regulation of multicellular organismal development | 1667 | 247 | 2.48E-29 | 5.50E-26 | |
Go regulation of transport | 1799 | 257 | 5.10E-28 | 7.54E-25 | |
Go regulation of cell differentiation | 1488 | 224 | 1.29E-27 | 1.43E-24 | |
Go regulation of cell proliferation | 1492 | 221 | 2.73E-26 | 2.42E-23 | |
Go neurogenesis | 1401 | 211 | 4.37E-26 | 3.23E-23 | |
Go regulation of cell death | 1471 | 218 | 5.66E-26 | 3.58E-23 | |
Go locomotion | 1111 | 179 | 1.16E-25 | 6.41E-23 | |
Go positive regulation of molecular function | 1786 | 248 | 3.00E-25 | 1.48E-22 | |
Go regulation of transcription from rna polymerase ii promoter | 1780 | 246 | 9.31E-25 | 4.13E-22 | |
Hallmark uv response dn | 144 | 37 | 9.77E-13 | 4.88E-11 | |
Hallmark oestrogen response early | 200 | 41 | 1.94E-10 | 4.84E-09 | |
Hallmark epithelial mesenchymal transition | 199 | 34 | 6.07E-07 | 8.57E-06 | |
Hallmark complement | 200 | 34 | 6.86E-07 | 8.57E-06 | |
Hallmark androgen response | 100 | 21 | 1.68E-06 | 9.69E-06 | |
Hallmark hypoxia | 200 | 33 | 1.94E-06 | 9.69E-06 | |
Hallmark allograft rejection | 200 | 33 | 1.94E-06 | 9.69E-06 | |
Hallmark il2 stat5 signalling | 200 | 33 | 1.94E-06 | 9.69E-06 | |
Hallmark p53 pathway | 200 | 33 | 1.94E-06 | 9.69E-06 | |
Hallmark myogenesis | 200 | 33 | 1.94E-06 | 9.69E-06 | |
Blood mQTLs | Go intracellular signal transduction | 1568 | 330 | 9.02e-46 | 4.00e-42 |
Go positive regulation of molecular function | 1786 | 345 | 2.00e-39 | 4.44e-36 | |
Go neurogenesis | 1401 | 291 | 3.12e-39 | 4.62e-36 | |
Go regulation of multicellular organismal development | 1667 | 326 | 2.39e-38 | 2.29e-35 | |
Go regulation of hydrolase activity | 1325 | 278 | 2.58e-38 | 2.29e-35 | |
Go regulation of intracellular signal transduction | 1651 | 322 | 1.23e-37 | 9.08e-35 | |
Go positive regulation of catalytic activity | 1515 | 302 | 3.82e-37 | 2.12e-34 | |
Go tissue development | 1508 | 301 | 3.91e-37 | 2.12e-34 | |
Go locomotion | 1111 | 244 | 4.78e-37 | 2.12e-34 | |
Go regulation of cell differentiation | 1488 | 298 | 4.79e-37 | 2.12e-34 | |
Hallmark uv response dn | 144 | 48 | 5.31e-16 | 2.66e-14 | |
Hallmark oestrogen response early | 200 | 56 | 1.74e-14 | 4.35e-13 | |
Hallmark epithelial mesenchymal transition | 199 | 48 | 3.49e-10 | 5.25e-09 | |
Hallmark complement | 200 | 48 | 4.20e-10 | 5.25e-09 | |
Hallmark oestrogen response late | 200 | 46 | 4.04e-09 | 4.04e-08 | |
Hallmark myogenesis | 200 | 45 | 1.20e-08 | 1.00e-07 | |
Hallmark mitotic spindle | 200 | 44 | 3.48e-08 | 2.49e-07 | |
Hallmark p53 pathway | 200 | 43 | 9.80e-08 | 6.12e-07 | |
Hallmark apical junction | 199 | 42 | 2.32e-07 | 1.22e-06 | |
Hallmark tnfa signalling via nfkb | 200 | 42 | 2.68e-07 | 1.22e-06 |